Latest Form 4 insider transactions

Jennifer Scott Perry, Chief Operating Officer of Bicycle Therapeutics Plc, sold 1,500 shares of common stock on October 2, 2026.

Kevin Lee, CHIEF EXECUTIVE OFFICER and a Director of Bicycle Therapeutics Plc, sold 7,805 shares of common stock on October 2, 2026.

Agility Robotics, in a presentation detailing its proposed business combination with Churchill Capital Corp XI, highlighted the advancements of its Digit 5 humanoid robot and secured substantial multi-year orders.

Peter Kaiser, Chief Development Officer of Ocular Therapeutix, Inc, sold 9,990 shares of common stock on October 2, 2026 for $7.05 per share.

Robert Michael Mckee, President & CEO and a Director of Kodiak Gas Services, Inc., sold 2,666 shares of common stock on October 5, 2026 for $53.95 per share.

Jeffrey S. Heier, Chief Scientific Officer of Ocular Therapeutix, Inc, sold 10,869 shares of common stock on October 2, 2026 for $7.05 per share.

Medtronic plc has filed a document detailing an offer to exchange newly issued shares of MiniMed Group, Inc. for its own common stock.

Roku, Inc. has filed a Form 8-K to supplement its merger proxy statement with Fox Corporation, addressing shareholder demand letters and providing updated financial data.

Paul Buckman, a Director of Shoulder Innovations, Inc., received 1,275 shares of common stock on October 5, 2026.

Hans Edgar Bishop, a Director of Sana Biotechnology, Inc., received 8,680 shares of common stock on October 5, 2026.

Ip Fibre Devices Ltd reported changes in beneficial ownership of Ipg Photonics Corp common stock on October 2, 2026.

Agility Robotics, in conjunction with Churchill Capital Corp XI, presented an investor day detailing the upcoming Digit 5 robot, a Nasdaq listing, and significant order book growth.

Eugene A Scherbakov, a Director and 10% owner of Ipg Photonics Corp, sold 3,048 shares of common stock on October 2, 2026 for $85.30 per share.

Lauren Knausenberger, a Director of EnerSys, reported multiple transactions in common stock on October 2, 2026.

Rajeev A. Modi, SEE REMARKS of Elanco Animal Health Inc, received 67 shares of common stock on October 2, 2026.

David C Habiger, a Director of EnerSys, reported multiple transactions in common stock on October 2, 2026.

Jeffrey N Simmons, PRESIDENT, CEO AND DIRECTOR and a Director of Elanco Animal Health Inc, received 128 shares of common stock on October 2, 2026.

Blake Johnson, Chief Financial Officer of Granite Point Mortgage Trust Inc., reported multiple transactions in common stock on October 4, 2026.

James J. Tarangelo, EVP and CFO of Aramark, reported a transaction in 1,675 shares of common stock on October 2, 2026.

Megan Carlson, CAO and SVP, Finance of Butterfly Network, Inc., sold 10,114 shares of common stock on October 2, 2026 for $8.74 per share.

Douglas A Alexander, a Director of Amkor Technology, Inc., sold 5,000 shares of common stock on October 2, 2026 for $55.00 per share.

Robert M Vanhimbergen, EVP and CFO of Elanco Animal Health Inc, received 9 shares of common stock on October 2, 2026.

Marc A Bruno, COO, U.S. Food & Facilities of Aramark, reported a transaction in 13,620 shares of common stock on October 2, 2026.

Ian F Smith, a Director of Solid Biosciences Inc., reported multiple transactions in common stock on October 2, 2026.

Andrew Reardon, CLO & Secretary of Ligand Pharmaceuticals Inc, sold 5,000 shares of common stock on October 2, 2026.

Tamara Morytko, a Director of EnerSys, reported multiple transactions in common stock on October 2, 2026.

John J Zillmer, Chief Executive Officer and a Director of Aramark, reported a transaction in 67,219 shares of common stock on October 2, 2026.

Travis Alvin Thompson, Chief Financial Officer of Bicycle Therapeutics Plc, sold 972 shares of common stock on October 2, 2026.

Abigail Charpentier, EVP & Chief HR Officer of Aramark, reported multiple transactions in common stock on October 2, 2026.

Melar Acquisition Corp. I and Everli Global Inc. announce the SEC's effectiveness of their S-4 registration statement, a key step towards Everli's Nasdaq listing.